1. Background {#sec212431}
=============

*Toxoplasma gondii* is one of the most important infectious diseases, having a worldwide distribution. Acquired toxoplasmosis is usually benign and asymptomatic, but it can be dangerous and have serious consequences in immunocompromised people and pregnant women. The disease is transmitted through consumption of contaminated water and food, as well as across the placenta in women whose first acute exposure to *T. gondii* occurs during pregnancy ([@A36666R1], [@A36666R2]). The prevalence of toxoplasmosis in humans varies depending on age, geographic region, temperature, humidity, eating habits and the presence of cats in the home. About 30% to 60% of the world's human population is infected with *T. gondii* ([@A36666R3], [@A36666R4]).

Rapid and appropriate diagnosis of toxoplasmosis is of great importance, as timely diagnosis and appropriate treatment can significantly reduce complications of this disease ([@A36666R4]). Inoculating a susceptible animal with a sample from the patient, performing a cell culture and observing the organism in tissue sections or a smear prepared from body fluids is a process with suitable sensitivity and specificity to diagnose toxoplasmosis; however, this technique is not usually used in medical diagnostic laboratories, due to the need for special facilities, the relatively long time needed to determine the test result and the risk of human and environmental contamination. Detecting antibodies against *T. gondii* in an individual's serum is the common method to diagnose toxoplasmosis ([@A36666R5]).

IgM antibodies are usually produced within the first week of the disease and usually decrease within a few months; however, in some cases, they persist for years. IgG-type antibodies are produced after one or two weeks, reach their maximum level within six months and then fall to a minimum within two years but remain present throughout the patient's life ([@A36666R4]). Among the available methods to detect anti-*T. gondii* antibodies in serum, ELISA is the most suitable due to the simplicity of implementation, relatively high sensitivity, accessibility of materials and means in the form of commercially available kits and lack of need for expensive devices. Although methods such as immunoblotting and radioimmunoassay are also of suitable diagnostic value, they are not used in most medical diagnostic laboratories due to the complexity of implementation ([@A36666R4], [@A36666R6]).

The ELISA method does have some problems, including unacceptable false-positive and -negative results from kits; differing stability of immunoglobulins detectable by antigens used in these methods; and the incidence of false-positive results due to the presence of rheumatoid factors and natural antibodies, which complicate the interpretation of test results and the final test outcome ([@A36666R4], [@A36666R7]). Most of these problems are created by antigens used in the tests designed for this purpose. Past research has shown that the use of desirable antigens can lead to increased test sensitivity and decreased costs compared with commercial kits. In addition, diagnosing and distinguishing between the chronic and acute forms of this disease requires several serum tests performed at time intervals. This is important for the diagnosis of infection in pregnant women, as the parasite may be transmitted to the fetus during the period of diagnosis. Several studies have been conducted to identify compounds of *T. gondii* for use as antigens in serological tests designed to diagnose toxoplasmosis to resolve the above-mentioned problems ([@A36666R6], [@A36666R7]).

2. Objectives {#sec212432}
=============

In this study, an indigenous diagnostic ELISA kit was prepared and its sensitivities and specificities were compared with commercial kits using the above-mentioned strain antigens. The commercially available kits are all produced in other countries using non-Iranian RH antigens, which may affect the results. In this study, due to the high sensitivity and specificity of ELISA (98% - 99%) for the diagnosis of toxoplasmosis, this method is considered as the reference for the prepared indigenous kit.

3. Methods {#sec212436}
==========

3.1. Antigen Preparation {#sec212433}
------------------------

The local RH strain of *T. gondii* was prepared for ELISA testing according to the method described by Dahl and Johnson ([@A36666R8]), with some modifications. Fifty male mice BALB/C with average weight of 25 - 30 gm, 5 - 6 weeks of age, were inoculated intraperitoneally with 0.02 mL of *T. gondii* RH strain parasite and 10^9^ tachyzoites. After 4 days, 1 mL of sterile saline was injected intraperitoneally and then aspirated and examined under a light microscope. Next, 0.02 mL of the fluid was placed into the peritoneal cavity of other mice for maintenance. The fluid was centrifuged and washed with PBS containing Tris-buffered ammonium chloride and incubated in a water bath to destroy red blood cells. The suspension was centrifuged and washed and forced through a syringe (needle size 27) to release the tachyzoites from the peritoneal cells. These were filtered through polycarbonate membrane (pore size 3 mm), centrifuged and washed. After washing, the tachyzoites were counted and their viability was determined using trypan blue stain. The antigens were sonicated in an ice bath 5 times for 30 s and centrifuged at 12000 rpm for 45 min at 4°C. Protein concentration was determined using the method described by Lowry et al. ([@A36666R9]).

3.2. Serum Samples {#sec212434}
------------------

In this study, 200 serum samples from patients with *T. gondii* whose IgM and IgG antibodies had been detected using commercial kits were selected to assess the sensitivity of the prepared indigenous test. The specificity of the method was evaluated using 40 heterologous serum samples (10 serum samples each from groups of patients with tuberculosis, leukemia and hydatid cysts). The patients were confirmed to be healthy (having no anti-*T. gondii* IgG and IgM antibodies in their serum) using commercial ELISA kits. In addition, 200 negative-control serum samples were obtained from clinically healthy individuals.

3.3. Design of Indigenous ELISA Using Local Antigens from the RH Strain of T. gondii {#sec212435}
------------------------------------------------------------------------------------

The optimum dilutions were determined by checkerboard titration of antigen, serum and conjugate as described by Lind et al. ([@A36666R10]), with some modifications. Microplates (Greiner, Germany) were coated with 100 µL of sonicated tachyzoites of *T. gondii* RH strain with 0.3 mg/mL concentration, diluted 1:50 in carbonate buffer (pH = 9.6), and then incubated 180 min at 37°C.

The plates were washed three times with 300 µL PBS containing 0.1% Tween 20 and blocked with 5% nonfat dry milk for 60 min at 37°C. After washing, 100 µL of serum sample, diluted 1:10 in PBS, was added and the microplate was incubated for 90 min at 37°C. After removing as above, 100 µL of alkaline phosphatase-labeled anti-goat conjugate (Sigma-Aldrich), diluted 1:3000 in PBS for IgG and 1:1000 for IgM, was added to the wells, and then the microplates were incubated at 37°C for 60 minutes. After removing, 100 µL of substrate solution (10 mg/mL 4-nitrophenylphosphate in 10 ml diethanolamine buffer, pH = 9.6) was added and the microplate was left for 30 min at room temperature. The reaction was stopped with 100 µL of 20% sulfuric acid, and the optical density at 450 nm was read in an ELISA reader (ELX800-Biotec). The cutoff value of optical densities (OD) was determined by the method of Hillyer et al. ([@A36666R11]): the mean OD of negative control sera plus two standard deviations.

4. Results {#sec212437}
==========

The results obtained with commercial ELISA kits and ELISA using local antigens for *T. gondii* antibody detection were as follows. Serum samples from 100 healthy individuals were tested using indigenous ELISA with anti-*T. gondii* IgG, and the cutoff value with 95% confidence was detected to be 0.368. Similarly, serum samples from 100 healthy individuals were examined using ELISA with anti-*T. gondii* IgM, with a cutoff value of 0.369. Patient serum samples containing anti-*T. gondii* IgG tested positive with indigenous ELISA in 98 of 100 cases (98%); thus, the sensitivity of the test was estimated to be 98%. The sensitivity of commercial ELISA was 100% ([Table 1](#tbl53540){ref-type="table"}).

###### Laboratory Results of Serum Samples Containing anti-*T. gondii* IgG from the RH Strain of *T. gondii* Using Indigenous ELISA

  Number   OD      Number   OD      Number   OD      Number   OD
  -------- ------- -------- ------- -------- ------- -------- -------
  **1**    0.520   26       0.513   51       0.471   76       0.602
  **2**    0.508   27       0.472   52       0.401   77       0.531
  **3**    0.473   28       0.453   53       0.465   78       0.431
  **4**    0.460   29       0.506   54       0.485   79       0.530
  **5**    0.486   30       0.463   55       0.604   80       0.419
  **6**    0.470   31       0.508   56       0.435   81       0.519
  **7**    0.482   32       0.401   57       0.590   82       0.450
  **8**    0.465   33       0.505   58       0.513   83       0.422
  **9**    0.430   34       0.569   59       0.413   84       0.432
  **10**   0.526   35       0.426   60       0.572   85       0.400
  **11**   0.440   36       0.400   61       0.412   86       0.520
  **12**   0.459   37       0.503   62       0.467   87       0.487
  **13**   0.399   38       0.501   63       0.433   88       0.300
  **14**   0.453   39       0.409   64       0.439   89       0.417
  **15**   0.411   40       0.445   65       0.416   90       0.500
  **16**   0.455   41       0.300   66       0.492   91       0.438
  **17**   0.512   42       0.480   67       0.515   92       0.448
  **18**   0.502   43       0.440   68       0.504   93       0.601
  **19**   0.432   44       0.403   69       0.436   94       0.419
  **20**   0.405   45       0.451   70       0.503   95       0.481
  **21**   0.483   46       0.600   71       0.521   96       0.484
  **22**   0.600   47       0.511   72       0.450   97       0.442
  **23**   0.451   48       0.417   73       0.592   98       0.485
  **24**   0.421   49       0.406   74       0.441   99       0.407
  **25**   0.601   50       0.450   75       0.508   100      0.503

The 100 patient serum samples containing anti-*T. gondii* IgM tested positive with indigenous ELISA in 99 cases (99%), establishing the sensitivity of the test as 99%, whereas the sensitivity of commercial ELISA was 100% ([Table 2](#tbl53541){ref-type="table"}). There was no statistically significant difference between the tests (P value ≥ 0.05). To determine specificity, 40 serum samples were taken from patients with leukemia, hydatid cyst or tuberculosis. These samples, when examined with indigenous ELISA using anti-*T. gondii* IgG, gave a negative result in all 40 cases (100%). Thus, the specificity of the test was determined to be 100%, equivalent to commercial ELISA.

###### Laboratory Results of Serum Samples Containing anti-*T. gondii* IgM from the RH Strain of *T. gondii* Using Indigenous ELISA

  Number   OD      Number   OD      Number   OD      Number   OD
  -------- ------- -------- ------- -------- ------- -------- -------
  **1**    0.637   26       0.651   51       0.423   76       0.432
  **2**    0.853   27       0.546   52       0.525   77       0.660
  **3**    0.451   28       0.620   53       0.425   78       0.485
  **4**    0.448   29       0.434   54       0.435   79       0.522
  **5**    0.538   30       0.412   55       0.511   80       0.410
  **6**    0.528   31       0.514   56       0.426   81       0.506
  **7**    0.729   32       0.499   57       0.601   82       0.462
  **8**    0.551   33       0.453   58       0.501   83       0.460
  **9**    0.645   34       0.508   59       0.408   84       0.520
  **10**   0.456   35       0.601   60       0.520   85       0.415
  **11**   0.438   36       0.446   61       0.451   86       0.541
  **12**   0.616   37       0.450   62       0.440   87       0.416
  **13**   0.482   38       0.503   63       0.635   88       0.650
  **14**   0.433   39       0.430   64       0.850   89       0.536
  **15**   0.661   40       0.615   65       0.431   90       0.619
  **16**   0.486   41       0.532   66       0.422   91       0.433
  **17**   0.483   42       0.647   67       0.518   92       0.411
  **18**   0.523   43       0.410   68       0.721   93       0.513
  **19**   0.412   44       0.540   69       0.551   94       0.452
  **20**   0.507   45       0.413   70       0.643   95       0.507
  **21**   0.464   46       0.498   71       0.409   96       0.300
  **22**   0.462   47       0.402   72       0.455   97       0.600
  **23**   0.416   48       0.522   73       0.437   98       0.445
  **24**   0.542   49       0.511   74       0.615   99       0.449
  **25**   0.417   50       0.711   75       0.481   100      0.500

However, when the same samples were examined with indigenous ELISA using anti-*T. gondii* IgM, the results were 28.6% among leukemia patients, 21.4% for hydatid cyst patients and 16.7% for tuberculosis patients. Semiquantitative analysis using Pearson's correlation coefficient gave similar results: 0.69 R value and P ≤ 0.001 for the correlation between commercial and indigenous ELISA ([Figure 1](#fig38996){ref-type="fig"}).

![Graph of Pearson's Correlation Coefficient in 400 Samples Containing Anti-*T. gondii* IgG and IgM Using Indigenous ELISA and Commercial ELISA](jjm-09-10-36666-i001){#fig38996}

5. Discussion {#sec212438}
=============

It is estimated that one third of the people in the world have been exposed to the parasite *T. gondii* ([@A36666R3]). In Iran, toxoplasmosis continues to be a public health problem, and the seroprevalence of this infection is highly varied in different regions ([@A36666R2], [@A36666R12]-[@A36666R14]). Khuzestan, southwest of Iran, is endemic for *T. gondii*. Previously, we have detected *T. gondii* from a variety of human and animal sources ([@A36666R1], [@A36666R2], [@A36666R15]-[@A36666R17]). Therefore, epidemiological study of the parasite is essential in this region.

One of the most commonly used screening methods for *T. gondii* infection is ELISA. ELISA is fast and easy to interpret, making it appropriate for routine screening of humans and having the potential for automatization ([@A36666R4], [@A36666R6]). One of the customary questions in this regard deals with the specificity and sensitivity of commercial ELISA kits. *T. gondii* is known to have different lineages, I, II and III, as well as genetic diversity in different parts of the world ([@A36666R17]-[@A36666R21]); could these characteristics affect the serological results? Accuracy of antigen preparation and standardization are important factors for researchers. Standardization of assays for *T. gondii*-specific antigens is also important for monitoring infection, as large differences in assay calibration could lead to misinterpretations of the clinical course when different assays are used. Furthermore, purchasing commercial kits can be a major problem for geographically remote or developing countries, where infectious diseases are typically the main public health problem. Therefore, preparation of indigenous diagnostic kits is very significant.

In the present study, we compared the sensitivity and specificity of standard ELISA assays using locally isolated antigens and using a commercial kit. The commercial ELISA kit gave more sensitive and more specific results (both 100%) than the indigenous ELISA using anti-*T. gondii* IgG (98% and 99%). The specificity of indigenous ELISA using anti-*T. gondii* IgM was far less and probably proved a cross-reaction with other disease antigens. However, no statistically significant differences were found between the tests.

Our results can be compared with those in a 1995 study by Zhang et al. (88.9% sensitivity and 95.7% specificity) ([@A36666R22]), a 1990 study by Malik et al. (62.5% sensitivity) ([@A36666R23]), a 2007 study by Shaapan et al. (49% sensitivity with local antigens from the RH strain of *T. gondii*) ([@A36666R24]), a 2011 study by Hassanain et al. (61.4% sensitivity) ([@A36666R25]) and a 2013 study by Al-Olayan (50% sensitivity) ([@A36666R26]). The higher level of sensitivity in our study might be linked to our antigen preparation methods and to our region. Most specificity in our study showed non- cross reaction. McCabe and Remington found in 1988 that the peritoneal fluid of mice infected with the RH strain of *T. gondii* was able to characterize anti-*T. gondii* IgG in human serum ([@A36666R27]). Yamamoto et al. reported in 1998 that the antigenic compounds in the peritoneal fluid of mice infected with tachyzoites of the RH strain of *T. gondii* accurately characterized anti-*T. gondii* IgG, IgM and IgA in human serum samples and could be utilized as an antigen in serological tests ([@A36666R28]). Ghazy et al. recommended utilization of 65 KDa antigen of *T. gondii* in commercial kits for diagnosis of toxoplasmosis in human serum ([@A36666R29]).

Our conclusion is that local antigens are more suitable than commercial antigens for this purpose, as they allow for easier preparation, less expense and greater sensitivity. We recommend utilization of soluble antigens obtained from locally isolated tachyzoites to diagnose toxoplasmosis in humans using ELISA, which showed statistically equivalent diagnostic potency and sensitivity in our study compared with a commercial ELISA kit.
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